Novel treatment approaches to cachexia and sarcopenia: Highlights from the 5th Cachexia Conference

Thomas Kung, Jochen Springer, Wolfram Doehner, Stefan D. Anker, Stephan Von Haehling

Research output: Contribution to journalArticlepeer-review

Abstract

Cachexia is an illness that may occur in terminal stages of many chronic illnesses including cancer, chronic heart failure, chronic renal failure or chronic obstructive pulmonary disease. Effective treatments are urgently needed in order to improve the patients' quality of life and their survival. We report highlights from the 5th Cachexia Conference held in December 2009 in Barcelona, Spain. Novel therapeutic approaches shown here include melanocortin-4 receptor antagonists, myostatin inhibition, β-blockers, IL-6 antagonism synthetic ghrelin and vitamin D.

Original languageEnglish
Pages (from-to)579-585
Number of pages7
JournalExpert Opinion on Investigational Drugs
Volume19
Issue number4
DOIs
Publication statusPublished - 2010

Keywords

  • Cachexia
  • IL-6 antagonism
  • Melanocortin-4 receptor antagonist
  • Myostatin
  • Treatment
  • β-blocker

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Medicine(all)

Fingerprint

Dive into the research topics of 'Novel treatment approaches to cachexia and sarcopenia: Highlights from the 5th Cachexia Conference'. Together they form a unique fingerprint.

Cite this